Genpact (G) Lowered to “Sell” at Zacks Investment Research
Genpact (NYSE:G) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday.
According to Zacks, “Genpact delivered stellar fourth-quarter results. Revenues for the quarter also increased year over year. The company provided an encouraging fiscal 2018 revenue guidance. Genpact’s domain expertise in business analytics, digital and consulting sectors is a key catalyst. Its performance is driven by growth in Global Client BPO and transformation services. Additionally, strong clientele and aggressive share buyback on stable cash flows are tailwinds. However, customer concentration is a concern for the company. Acquisitions have also negatively impacted the company's balance sheet. Additionally, anticipated government regulation in the U.S. over outsourcing (H1B Visa, Cross-border tax) is a headwind. Also, stiff competition from the like Cognizant and Accenture adds to its woes.”
Several other research analysts have also recently weighed in on G. Robert W. Baird restated a “buy” rating and set a $38.00 price target on shares of Genpact in a report on Friday, November 10th. Cantor Fitzgerald restated a “buy” rating and set a $36.00 price target on shares of Genpact in a report on Wednesday, November 8th. Citigroup cut their price target on shares of Genpact from $39.00 to $37.50 and set a “buy” rating on the stock in a report on Tuesday. JPMorgan Chase & Co. cut their price target on shares of Genpact from $38.00 to $37.00 and set a “neutral” rating on the stock in a report on Wednesday. Finally, BMO Capital Markets boosted their price target on shares of Genpact to $35.00 and gave the stock a “market perform” rating in a report on Tuesday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the company’s stock. Genpact presently has a consensus rating of “Buy” and a consensus target price of $34.65.
Genpact (NYSE:G) last issued its quarterly earnings data on Monday, February 12th. The business services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.41 by $0.02. The firm had revenue of $734.41 million during the quarter, compared to analysts’ expectations of $723.55 million. Genpact had a net margin of 9.61% and a return on equity of 23.53%. The business’s revenue was up 7.7% on a year-over-year basis. During the same period last year, the company earned $0.43 earnings per share. sell-side analysts anticipate that Genpact will post 1.61 EPS for the current fiscal year.
In other Genpact news, insider Arvinder Singh sold 22,690 shares of the business’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $33.95, for a total value of $770,325.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Piyush Mehta sold 12,500 shares of the business’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $32.00, for a total transaction of $400,000.00. Following the completion of the transaction, the senior vice president now owns 77,944 shares in the company, valued at $2,494,208. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,660,470 shares of company stock worth $50,598,982. Corporate insiders own 1.41% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. boosted its stake in Genpact by 6.6% in the fourth quarter. BlackRock Inc. now owns 12,772,040 shares of the business services provider’s stock valued at $405,384,000 after acquiring an additional 785,600 shares during the last quarter. Brown Advisory Inc. boosted its stake in Genpact by 2.0% in the third quarter. Brown Advisory Inc. now owns 12,598,190 shares of the business services provider’s stock valued at $362,198,000 after acquiring an additional 247,088 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of Genpact by 10.4% in the fourth quarter. Alliancebernstein L.P. now owns 3,158,448 shares of the business services provider’s stock valued at $100,249,000 after purchasing an additional 297,894 shares during the period. Pzena Investment Management LLC raised its position in shares of Genpact by 7.7% in the fourth quarter. Pzena Investment Management LLC now owns 2,843,211 shares of the business services provider’s stock valued at $90,243,000 after purchasing an additional 204,077 shares during the period. Finally, Congress Asset Management Co. MA raised its position in shares of Genpact by 1.9% in the fourth quarter. Congress Asset Management Co. MA now owns 2,665,625 shares of the business services provider’s stock valued at $84,607,000 after purchasing an additional 50,390 shares during the period. Hedge funds and other institutional investors own 92.00% of the company’s stock.
Genpact Company Profile
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.